JP2019022518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019022518A5 JP2019022518A5 JP2018194898A JP2018194898A JP2019022518A5 JP 2019022518 A5 JP2019022518 A5 JP 2019022518A5 JP 2018194898 A JP2018194898 A JP 2018194898A JP 2018194898 A JP2018194898 A JP 2018194898A JP 2019022518 A5 JP2019022518 A5 JP 2019022518A5
- Authority
- JP
- Japan
- Prior art keywords
- rodent
- exon
- human
- humanized
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283984 Rodentia Species 0.000 claims 57
- 108090000172 Interleukin-15 Proteins 0.000 claims 45
- 102000003812 Interleukin-15 Human genes 0.000 claims 27
- 101001055157 Homo sapiens Interleukin-15 Proteins 0.000 claims 16
- 102000056003 human IL15 Human genes 0.000 claims 16
- 239000012634 fragment Substances 0.000 claims 12
- 241000700159 Rattus Species 0.000 claims 6
- 230000001105 regulatory effect Effects 0.000 claims 6
- 210000001519 tissue Anatomy 0.000 claims 6
- 238000011144 upstream manufacturing Methods 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 108700024394 Exon Proteins 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 210000000981 epithelium Anatomy 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361891013P | 2013-10-15 | 2013-10-15 | |
| US61/891,013 | 2013-10-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549191A Division JP6492095B2 (ja) | 2013-10-15 | 2014-10-15 | ヒト化ｉｌ−１５動物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019182817A Division JP2019216750A (ja) | 2013-10-15 | 2019-10-03 | ヒト化ｉｌ−１５動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019022518A JP2019022518A (ja) | 2019-02-14 |
| JP2019022518A5 true JP2019022518A5 (enExample) | 2019-04-18 |
| JP6600061B2 JP6600061B2 (ja) | 2019-10-30 |
Family
ID=51830649
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549191A Active JP6492095B2 (ja) | 2013-10-15 | 2014-10-15 | ヒト化ｉｌ−１５動物 |
| JP2018194898A Active JP6600061B2 (ja) | 2013-10-15 | 2018-10-16 | ヒト化ｉｌ−１５動物 |
| JP2019182817A Pending JP2019216750A (ja) | 2013-10-15 | 2019-10-03 | ヒト化ｉｌ−１５動物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549191A Active JP6492095B2 (ja) | 2013-10-15 | 2014-10-15 | ヒト化ｉｌ−１５動物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019182817A Pending JP2019216750A (ja) | 2013-10-15 | 2019-10-03 | ヒト化ｉｌ−１５動物 |
Country Status (27)
| Country | Link |
|---|---|
| US (5) | US9155290B2 (enExample) |
| EP (3) | EP3138397B1 (enExample) |
| JP (3) | JP6492095B2 (enExample) |
| KR (1) | KR102376041B1 (enExample) |
| CN (2) | CN109090037B (enExample) |
| AU (2) | AU2014337526B2 (enExample) |
| BR (1) | BR112016008175A2 (enExample) |
| CA (1) | CA2926090C (enExample) |
| CY (2) | CY1118675T1 (enExample) |
| DK (2) | DK3138397T3 (enExample) |
| ES (2) | ES2613379T3 (enExample) |
| HR (2) | HRP20170380T1 (enExample) |
| HU (2) | HUE033272T2 (enExample) |
| IL (2) | IL244525B (enExample) |
| LT (2) | LT2908626T (enExample) |
| MX (1) | MX2016004781A (enExample) |
| NZ (1) | NZ718655A (enExample) |
| PL (2) | PL3138397T3 (enExample) |
| PT (2) | PT3138397T (enExample) |
| RS (2) | RS55472B1 (enExample) |
| RU (1) | RU2674910C2 (enExample) |
| SG (2) | SG10201607768YA (enExample) |
| SI (2) | SI3138397T1 (enExample) |
| SM (3) | SMT201700024T1 (enExample) |
| TR (1) | TR201904342T4 (enExample) |
| WO (1) | WO2015057758A1 (enExample) |
| ZA (1) | ZA201601676B (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4502152A3 (en) | 2009-10-06 | 2025-04-30 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice and engraftment |
| PT4233537T (pt) | 2011-02-15 | 2025-09-08 | Regeneron Pharma | Ratinhos humanizados para m-csf e utilizações dos mesmos |
| KR102241962B1 (ko) | 2012-09-07 | 2021-04-20 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| DK4389764T3 (da) | 2012-11-05 | 2026-04-13 | Regeneron Pharma | Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf |
| JP6492095B2 (ja) | 2013-10-15 | 2019-03-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヒト化ｉｌ−１５動物 |
| US20150143559A1 (en) | 2013-11-19 | 2015-05-21 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized a proliferation-inducing ligand gene |
| MX2016014504A (es) | 2014-05-05 | 2017-05-23 | Regeneron Pharma | Animales c5 y c3 humanizados. |
| NO2785538T3 (enExample) | 2014-05-07 | 2018-08-04 | ||
| EP3482629B1 (en) | 2014-05-19 | 2020-11-25 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals expressing human epo |
| BR112017010490A2 (pt) | 2014-12-05 | 2018-04-03 | Regeneron Pharma | roedor, polipeptídeo cd47, célula ou tecido de roedor isolado, célula-tronco emprionária de roedor, embrião de roedor, e, métodos de produzir um roedor, de fornecimento de um roedor, de enxerto de células humanas em um roedor, de avaliação de eficácia terapêutica de uma droga direcionada a células humanas e de avaliar as propriedades farmacocinéticas, de avaliar a toxicidade específica e inespecífica de uma droga direcionada ao cd47 humano. |
| ES2950399T3 (es) * | 2015-04-13 | 2023-10-09 | Regeneron Pharma | Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos |
| WO2017136712A1 (en) | 2016-02-04 | 2017-08-10 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered angptl8 gene |
| CN109068621B (zh) | 2016-02-29 | 2021-07-20 | 再生元制药公司 | 具有人源化的tmprss基因的啮齿类动物 |
| US10912287B2 (en) | 2016-06-28 | 2021-02-09 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd | Genetically modified mice expressing humanized PD-1 |
| WO2018041120A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric tigit |
| WO2018041119A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric ox40 |
| WO2018041118A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric pd-l1 |
| CN107815467B (zh) | 2016-08-31 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| WO2018041121A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric ctla-4 |
| CN107815468B (zh) | 2016-08-31 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| WO2018086594A1 (en) | 2016-11-11 | 2018-05-17 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric tim-3 |
| CN108070613B (zh) | 2016-11-11 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| WO2018102546A1 (en) | 2016-11-30 | 2018-06-07 | The Jackson Laboratory | Humanized mouse model with improved human innate immune cell development |
| CN108239659B (zh) | 2016-12-23 | 2020-03-03 | 百奥赛图江苏基因生物技术有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| CN108424928B (zh) | 2016-12-30 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| CN108467873B (zh) | 2017-03-17 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用 |
| CN108588126B (zh) | 2017-03-31 | 2020-04-10 | 北京百奥赛图基因生物技术有限公司 | Cd47基因人源化改造动物模型的制备方法及应用 |
| WO2018177441A1 (en) | 2017-03-31 | 2018-10-04 | Beijing Biocytogen Co., Ltd | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα |
| CN109136274B (zh) | 2017-06-19 | 2021-04-23 | 百奥赛图江苏基因生物技术有限公司 | 人源化cd40基因改造动物模型的制备方法及应用 |
| CN109136275B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化gitr基因改造动物模型的制备方法及应用 |
| CN109136261B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化cd28基因改造动物模型的制备方法及应用 |
| IL272475B2 (en) * | 2017-08-09 | 2025-05-01 | Jackson Lab | Immunodeficient mice expressing interleukin 15 |
| WO2019067875A1 (en) | 2017-09-29 | 2019-04-04 | Regeneron Pharmaceuticals, Inc. | NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE |
| WO2019072241A1 (en) | 2017-10-13 | 2019-04-18 | Beijing Biocytogen Co., Ltd | NON-HUMAN ANIMAL GENETICALLY MODIFIED WITH PD-1 HUMAN OR CHIMERIC |
| WO2019114768A1 (en) | 2017-12-12 | 2019-06-20 | Biocytogen Jiangsu Co., Ltd. | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e |
| CA3098040A1 (en) | 2018-07-16 | 2020-01-23 | Regeneron Pharmaceuticals, Inc. | Non-human animal models of ditra disease and uses thereof |
| CN111057721B (zh) | 2018-10-12 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化IL-4和/或IL-4Rα改造动物模型的制备方法及应用 |
| WO2020125763A1 (en) | 2018-12-20 | 2020-06-25 | Biocytogen Jiangsu Co., Ltd. | Genetically modified non-human animal with human or chimeric lag3 |
| CN111304248B (zh) * | 2018-12-25 | 2021-08-24 | 百奥赛图江苏基因生物技术有限公司 | 人源化细胞因子il15基因改造非人动物的构建方法及应用 |
| WO2020147829A1 (zh) * | 2019-01-17 | 2020-07-23 | 北京百奥赛图基因生物技术有限公司 | 人源化转基因动物 |
| JP7506686B2 (ja) | 2019-04-04 | 2024-06-26 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化凝固因子１２遺伝子座を含む非ヒト動物 |
| WO2020247452A1 (en) | 2019-06-04 | 2020-12-10 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use |
| CN113939595A (zh) | 2019-06-07 | 2022-01-14 | 瑞泽恩制药公司 | 包括人源化白蛋白基因座的非人动物 |
| WO2021129766A1 (zh) * | 2019-12-25 | 2021-07-01 | 江苏集萃药康生物科技股份有限公司 | 一种il-15人源化小鼠模型及其用途 |
| WO2021154791A1 (en) * | 2020-01-28 | 2021-08-05 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized pnpla3 locus and methods of use |
| CN111485001A (zh) * | 2020-04-14 | 2020-08-04 | 澎立生物医药技术（上海）有限公司 | 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法 |
| CN112481303B (zh) * | 2021-02-09 | 2021-05-25 | 百奥赛图(北京)医药科技股份有限公司 | Il15ra基因人源化非人动物及其构建方法和应用 |
| WO2025212991A1 (en) | 2024-04-05 | 2025-10-09 | Regeneron Pharmaceuticals, Inc. | Rodent models of disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058914A2 (en) * | 2000-02-08 | 2001-08-16 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the interleukin 15 gene |
| US7759541B2 (en) * | 2004-12-13 | 2010-07-20 | Iti Life Sciences | Transgenic animals for assessing drug metabolism and toxicity |
| WO2007001677A2 (en) * | 2005-05-17 | 2007-01-04 | University Of Connecticut | Compositions and methods for immunomodulation in an organism |
| EP3456191A1 (en) * | 2008-06-27 | 2019-03-20 | Merus N.V. | Antibody producing non-human mammals |
| RU2425880C2 (ru) * | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| EP4502152A3 (en) | 2009-10-06 | 2025-04-30 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice and engraftment |
| EP3498730B1 (en) * | 2009-12-21 | 2026-01-28 | Regeneron Pharmaceuticals, Inc. | Humanized fc gamma r mice |
| PT4233537T (pt) | 2011-02-15 | 2025-09-08 | Regeneron Pharma | Ratinhos humanizados para m-csf e utilizações dos mesmos |
| US9043996B2 (en) * | 2011-10-28 | 2015-06-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
| RS63220B1 (sr) * | 2011-10-28 | 2022-06-30 | Regeneron Pharma | Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc) |
| KR102295746B1 (ko) | 2011-10-28 | 2021-09-01 | 리제너론 파아마슈티컬스, 인크. | 유전자 변형된 주요 조직적합성 복합체 마우스 |
| SI2818478T1 (sl) | 2011-10-28 | 2017-07-31 | Regeneron Pharmaceuticals, Inc. | Humanizirani il-6 in receptor il-6 |
| US8962913B2 (en) | 2012-06-18 | 2015-02-24 | Regeneron Pharmaceuticals, Inc. | Humanized IL-7 rodents |
| KR102241962B1 (ko) | 2012-09-07 | 2021-04-20 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| DK4389764T3 (da) | 2012-11-05 | 2026-04-13 | Regeneron Pharma | Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf |
| SI2958937T1 (sl) | 2013-02-22 | 2018-12-31 | Regeneron Pharmaceuticals, Inc. | Miš, ki izraža humanizirani poglavitni histokompatibilnostni kompleks |
| HRP20231121T1 (hr) | 2013-09-23 | 2023-12-22 | Regeneron Pharmaceuticals, Inc. | Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale |
| JP6492095B2 (ja) | 2013-10-15 | 2019-03-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヒト化ｉｌ−１５動物 |
-
2014
- 2014-10-15 JP JP2016549191A patent/JP6492095B2/ja active Active
- 2014-10-15 BR BR112016008175A patent/BR112016008175A2/pt not_active Application Discontinuation
- 2014-10-15 EP EP16192440.2A patent/EP3138397B1/en active Active
- 2014-10-15 CN CN201810808707.3A patent/CN109090037B/zh active Active
- 2014-10-15 CN CN201480056455.3A patent/CN105744829B/zh active Active
- 2014-10-15 ES ES14790452.8T patent/ES2613379T3/es active Active
- 2014-10-15 SI SI201431130T patent/SI3138397T1/sl unknown
- 2014-10-15 SI SI201430109T patent/SI2908626T1/sl unknown
- 2014-10-15 HR HRP20170380TT patent/HRP20170380T1/hr unknown
- 2014-10-15 PL PL16192440T patent/PL3138397T3/pl unknown
- 2014-10-15 AU AU2014337526A patent/AU2014337526B2/en active Active
- 2014-10-15 WO PCT/US2014/060568 patent/WO2015057758A1/en not_active Ceased
- 2014-10-15 PL PL14790452T patent/PL2908626T3/pl unknown
- 2014-10-15 SM SM20170024T patent/SMT201700024T1/it unknown
- 2014-10-15 US US14/514,454 patent/US9155290B2/en active Active
- 2014-10-15 RS RS20161140A patent/RS55472B1/sr unknown
- 2014-10-15 MX MX2016004781A patent/MX2016004781A/es unknown
- 2014-10-15 RS RS20190349A patent/RS58465B1/sr unknown
- 2014-10-15 ES ES16192440T patent/ES2715949T3/es active Active
- 2014-10-15 SM SM20190177T patent/SMT201900177T1/it unknown
- 2014-10-15 KR KR1020167009228A patent/KR102376041B1/ko active Active
- 2014-10-15 NZ NZ718655A patent/NZ718655A/en unknown
- 2014-10-15 CA CA2926090A patent/CA2926090C/en active Active
- 2014-10-15 HU HUE14790452A patent/HUE033272T2/en unknown
- 2014-10-15 LT LTEP14790452.8T patent/LT2908626T/lt unknown
- 2014-10-15 HU HUE16192440A patent/HUE043969T2/hu unknown
- 2014-10-15 TR TR2019/04342T patent/TR201904342T4/tr unknown
- 2014-10-15 RU RU2016116847A patent/RU2674910C2/ru active
- 2014-10-15 DK DK16192440.2T patent/DK3138397T3/en active
- 2014-10-15 SG SG10201607768YA patent/SG10201607768YA/en unknown
- 2014-10-15 PT PT16192440T patent/PT3138397T/pt unknown
- 2014-10-15 LT LTEP16192440.2T patent/LT3138397T/lt unknown
- 2014-10-15 PT PT147904528T patent/PT2908626T/pt unknown
- 2014-10-15 DK DK14790452.8T patent/DK2908626T3/en active
- 2014-10-15 EP EP14790452.8A patent/EP2908626B1/en active Active
- 2014-10-15 EP EP18206034.3A patent/EP3461331A1/en not_active Withdrawn
- 2014-10-15 SG SG11201601828XA patent/SG11201601828XA/en unknown
-
2015
- 2015-09-01 US US14/842,342 patent/US20150366175A1/en not_active Abandoned
-
2016
- 2016-03-10 IL IL24452516A patent/IL244525B/en active IP Right Grant
- 2016-03-10 ZA ZA2016/01676A patent/ZA201601676B/en unknown
-
2017
- 2017-01-04 CY CY20171100008T patent/CY1118675T1/el unknown
- 2017-01-16 SM SM201700024T patent/SMT201700024B/it unknown
- 2017-12-06 US US15/832,976 patent/US10561125B2/en active Active
-
2018
- 2018-10-16 JP JP2018194898A patent/JP6600061B2/ja active Active
-
2019
- 2019-03-18 CY CY20191100323T patent/CY1121405T1/el unknown
- 2019-03-20 HR HRP20190542TT patent/HRP20190542T1/hr unknown
- 2019-10-03 JP JP2019182817A patent/JP2019216750A/ja active Pending
- 2019-10-10 IL IL269907A patent/IL269907B/en active IP Right Grant
-
2020
- 2020-01-02 US US16/732,400 patent/US11503813B2/en active Active
- 2020-12-08 AU AU2020286186A patent/AU2020286186B2/en active Active
-
2022
- 2022-10-17 US US18/047,014 patent/US12369570B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016123708A (ru) | Отличные от человека животные, содержащие гуманизированный ген фактора активации в-клеток | |
| HRP20170380T1 (hr) | Životinje s humaniziranim il-5 | |
| FI3434101T3 (fi) | Ei-ihmiseläimiä, joissa on humanisoitu signaalinsäätelyproteiinigeeni | |
| JP2017505127A5 (enExample) | ||
| RU2014148107A (ru) | Грызуны с гуманизированным il-7 | |
| RU2016123135A (ru) | Отличные от человека животные, содержащие гуманизированный ген индуцирующего пролиферацию лиганда | |
| CN104450602B (zh) | 非人哺乳动物神经精神疾病动物模型及其制备方法和用途 | |
| HRP20202034T1 (hr) | Neljudske životinje s genom za humanizirani diferencijacijski biljeg cd274 | |
| JP2014532416A5 (enExample) | ||
| JP2017521060A5 (enExample) | ||
| CN110269047A (zh) | 人源化IL-4和IL-4Rα动物 | |
| JP2017213006A5 (enExample) | ||
| RU2016143036A (ru) | Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы | |
| IL319209A (en) | Non-human animals containing a humanized ASGR1 locus | |
| JP2016526924A5 (enExample) | ||
| Liu et al. | Functional redundancy between human SHOX and mouse Shox2 genes in the regulation of sinoatrial node formation and pacemaking function | |
| JP2019506897A5 (enExample) | ||
| JP2019511918A5 (enExample) | ||
| RU2018131152A (ru) | Грызуны, характеризующиеся гуманизированным геном tmprss | |
| CN106282122A (zh) | 一种非人哺乳动物恐惧症或其相关疾病动物模型的建立方法及其用途 | |
| JP2024500153A5 (enExample) | ||
| Zhou et al. | Potential but limited redundant roles of MtPIN4, MtPIN5 and MtPIN10/SLM1 in the development of Medicago truncatula | |
| CN119752892B (zh) | 靶向敲除猪txlnb基因座的方法和应用 | |
| CN110904114A (zh) | 一种Gnb2基因的编码序列和Gnb2基因的编码序列在构建小鼠模型中的应用 | |
| RU2018140914A (ru) | Животные с гуманизированным геном il-15 |